Genetic Technologies
GENE
#10465
Rank
A$5.23 M
Marketcap
A$1.08
Share price
0.00%
Change (1 day)
-71.67%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of A-$0.04693 a decrease over its 2022 EPS that were of A-$0.03115.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023A-$0.0469350.65%
2022A-$0.03115-99.04%
2021A-$3.24-46.67%
2020A-$6.07-99.38%
2019A-$970.9110809.09%
2018A-$8.90-41.07%
2017A-$15.10-18.37%
2016A-$18.50-40.24%
2015A-$30.96-53.41%
2014A-$66.45-10.66%
2013A-$74.3871.3%
2012A-$43.42-622.73%
2011A$8.31-108.8%
2010A-$94.39-3.92%
2009A-$98.2573.47%
2008A-$56.6424.96%
2007A-$45.32-10.93%
2006A-$50.88-48.62%
2005A-$99.04-8.31%
2004A-$108.01
2003N/A-100%
2002A-$67.06-9.36%
2001A-$73.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.08N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$12.19N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$7.15N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.46N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A-$0.42N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
A-$3.91N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.11N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$108.25N/A๐Ÿ‡บ๐Ÿ‡ธ USA